Market Indices
Sector Heatmap
ANAB — AnaptysBio, Inc. Common Stock
NasdaqAnaptysBio, Inc. Common Stock
- O
- 48.97
- H
- 49.83
- L
- 48.28
- V
- 440.96K
ANAB — Latest News & Headlines
17 StoriesAnaptysBio (NASDAQ:ANAB) Stock Bumped Up to Buy by Wall Street Zen - MarketBeat
AnaptysBio (NASDAQ:ANAB) Stock Bumped Up to Buy by Wall Street Zen MarketBeat
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates Yahoo Finance
Director Hollings C. Renton plans to sell 5,000 AnaptysBio (ANAB) shares valued at about $249K. - stocktitan.net
Director Hollings C. Renton plans to sell 5,000 AnaptysBio (ANAB) shares valued at about $249K. stocktitan.net
How Return To Profit Will Impact AnaptysBio (ANAB) Investors - Simply Wall Street
How Return To Profit Will Impact AnaptysBio (ANAB) Investors Simply Wall Street
ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00 - GuruFocus
ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00 GuruFocus
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX), AnaptysBio (ANAB) and Vertex Pharmaceuticals (VRTX) The Globe and Mail
AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance - Yahoo Finance
AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance Yahoo Finance
Leerink Partners maintains Outperform rating on AnaptysBio, $81 price target - TradingView
Leerink Partners maintains Outperform rating on AnaptysBio, $81 price target TradingView
Is AnaptysBio (ANAB) Cheap On Its Royalty Story Despite Tax Driven Earnings? - Simply Wall Street
Is AnaptysBio (ANAB) Cheap On Its Royalty Story Despite Tax Driven Earnings? Simply Wall Street
Leerink Partners Issues Pessimistic Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price - MarketBeat
Leerink Partners Issues Pessimistic Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price MarketBeat
AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns? - Yahoo Finance
AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns? Yahoo Finance
JPMorgan Chase & Co. Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $60.00 - MarketBeat
JPMorgan Chase & Co. Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $60.00 MarketBeat
AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours - Yahoo Finance
AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours Yahoo Finance
AnaptysBio (NASDAQ:ANAB) Shares Down 6.2% - What's Next? - MarketBeat
AnaptysBio (NASDAQ:ANAB) Shares Down 6.2% - What's Next? MarketBeat
Q3 Earnings Estimate for AnaptysBio Issued By HC Wainwright - MarketBeat
Q3 Earnings Estimate for AnaptysBio Issued By HC Wainwright MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Analysts MarketBeat
Bank of America Corp DE Makes New $28.20 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat
Bank of America Corp DE Makes New $28.20 Million Investment in AnaptysBio, Inc. $ANAB MarketBeat